$5.73 Billion is the total value of Redmile Group, LLC's 75 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 24.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $767,975,000 | -31.7% | 12,957,222 | 0.0% | 13.39% | -19.5% | |
| ALLK | Sell | ALLAKOS INC | $225,693,000 | +19.2% | 2,131,796 | -3.8% | 3.94% | +40.5% |
| IGMS | IGM BIOSCIENCES INC | $225,258,000 | -21.0% | 3,425,455 | 0.0% | 3.93% | -6.8% | |
| ARGX | Sell | ARGENX SEsponsored adr | $220,636,000 | -7.3% | 730,582 | -7.6% | 3.85% | +9.3% |
| ADCT | Buy | ADC THERAPEUTICS SA | $204,497,000 | +11.6% | 7,529,329 | +0.1% | 3.57% | +31.6% |
| FOLD | AMICUS THERAPEUTICS INC | $198,633,000 | -0.9% | 20,799,303 | 0.0% | 3.46% | +16.8% | |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $194,352,000 | +82.1% | 7,483,706 | +17.8% | 3.39% | +114.7% |
| LIVN | Buy | LIVANOVA PLC | $173,507,000 | +85.6% | 2,191,019 | +97.1% | 3.03% | +118.6% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $171,845,000 | -35.0% | 1,975,006 | -3.8% | 3.00% | -23.3% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $164,308,000 | +63.1% | 3,043,298 | +1.0% | 2.87% | +92.3% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $164,102,000 | +33.7% | 2,793,708 | +10.4% | 2.86% | +57.5% |
| NVTA | Buy | INVITAE CORP | $151,176,000 | -3.6% | 5,317,477 | +14.4% | 2.64% | +13.7% |
| New | ADAGIO THERAPEUTICS INC | $137,152,000 | – | 3,246,960 | +100.0% | 2.39% | – | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $136,991,000 | -11.8% | 4,031,521 | -5.0% | 2.39% | +3.9% |
| REPL | Sell | REPLIMUNE GROUP INC | $120,875,000 | -24.9% | 4,078,112 | -2.7% | 2.11% | -11.5% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $115,746,000 | +15.4% | 6,466,277 | +0.3% | 2.02% | +36.1% |
| STTK | SHATTUCK LABS INC | $114,534,000 | -29.7% | 5,619,914 | 0.0% | 2.00% | -17.1% | |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $112,163,000 | -26.6% | 861,401 | +0.2% | 1.96% | -13.5% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $103,503,000 | -26.5% | 1,982,432 | -4.3% | 1.80% | -13.4% |
| SGEN | Sell | SEAGEN INC | $99,736,000 | -18.1% | 587,374 | -23.9% | 1.74% | -3.4% |
| New | ABSCI CORPORATION | $93,402,000 | – | 8,031,094 | +100.0% | 1.63% | – | |
| NRIX | Sell | NURIX THERAPEUTICS INC | $92,669,000 | +9.5% | 3,093,077 | -3.0% | 1.62% | +29.1% |
| VERV | Sell | VERVE THERAPEUTICS INC | $87,844,000 | -24.7% | 1,869,030 | -3.5% | 1.53% | -11.3% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $84,208,000 | +26.3% | 2,550,205 | +10.5% | 1.47% | +48.8% |
| RGNX | Sell | REGENXBIO INC | $84,175,000 | +1.3% | 2,008,001 | -6.1% | 1.47% | +19.4% |
| OSH | Sell | OAK STR HEALTH INC | $79,893,000 | -40.8% | 1,878,520 | -18.4% | 1.39% | -30.2% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $67,376,000 | -17.7% | 2,567,696 | -2.2% | 1.18% | -3.0% |
| PRTA | Sell | PROTHENA CORP PLC | $64,213,000 | +2.7% | 901,491 | -25.8% | 1.12% | +21.1% |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $63,847,000 | +27.7% | 864,435 | -5.4% | 1.11% | +50.5% |
| NVRO | Sell | NEVRO CORP | $63,186,000 | -35.9% | 542,932 | -8.7% | 1.10% | -24.5% |
| ANNX | Sell | ANNEXON INC | $62,328,000 | -19.2% | 3,349,185 | -2.2% | 1.09% | -4.7% |
| STOK | Sell | STOKE THERAPEUTICS INC | $60,597,000 | -26.8% | 2,381,958 | -3.1% | 1.06% | -13.7% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $60,064,000 | -13.7% | 2,687,444 | -4.2% | 1.05% | +1.7% |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $52,658,000 | -4.4% | 2,505,118 | -10.3% | 0.92% | +12.6% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $52,049,000 | -43.4% | 3,083,501 | -2.3% | 0.91% | -33.2% |
| ICUI | Sell | ICU MED INC | $51,933,000 | +13.2% | 222,526 | -0.2% | 0.91% | +33.4% |
| New | SOMALOGIC INC | $49,216,000 | – | 3,972,270 | +100.0% | 0.86% | – | |
| GMAB | Sell | GENMAB A/Ssponsored ads | $48,961,000 | -2.3% | 1,120,388 | -8.7% | 0.85% | +15.1% |
| ANTM | Buy | ANTHEM INC | $47,533,000 | +14.4% | 127,502 | +17.2% | 0.83% | +34.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $47,166,000 | +24.7% | 120,710 | +27.8% | 0.82% | +47.0% |
| IMGN | Sell | IMMUNOGEN INC | $46,825,000 | -20.0% | 8,258,345 | -7.0% | 0.82% | -5.7% |
| NUVB | NUVATION BIO INC | $45,138,000 | +6.8% | 4,541,009 | 0.0% | 0.79% | +25.7% | |
| EPZM | Sell | EPIZYME INC | $38,188,000 | -46.0% | 7,458,660 | -12.4% | 0.67% | -36.4% |
| MDVL | MEDAVAIL HOLDINGS INC | $34,236,000 | -76.2% | 11,724,726 | 0.0% | 0.60% | -71.9% | |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $32,480,000 | -38.8% | 3,816,709 | +18.0% | 0.57% | -28.0% |
| GRTS | Buy | GRITSTONE BIO INC | $30,468,000 | +49.9% | 2,821,085 | +26.7% | 0.53% | +76.4% |
| New | STEVANATO GROUP S P A | $30,044,000 | – | 1,187,025 | +100.0% | 0.52% | – | |
| ZYME | Sell | ZYMEWORKS INC | $25,616,000 | -21.4% | 882,097 | -6.1% | 0.45% | -7.3% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $25,357,000 | -29.9% | 3,507,235 | -10.5% | 0.44% | -17.4% |
| IMTX | IMMATICS N.V | $25,245,000 | +12.0% | 1,941,892 | 0.0% | 0.44% | +31.7% | |
| RCEL | Sell | AVITA MEDICAL INC | $23,855,000 | -17.6% | 1,346,217 | -4.6% | 0.42% | -2.8% |
| AMED | Buy | AMEDISYS INC | $22,421,000 | -30.9% | 150,376 | +13.5% | 0.39% | -18.5% |
| BVS | Buy | BIOVENTUS INC | $21,096,000 | -19.4% | 1,489,856 | +0.2% | 0.37% | -4.9% |
| ALVR | Sell | ALLOVIR INC | $20,973,000 | -32.9% | 836,912 | -47.2% | 0.37% | -21.0% |
| DYNS | Sell | DYNAMICS SPECIAL PURPOSE COR | $19,134,000 | -4.4% | 1,924,900 | -4.4% | 0.33% | +12.8% |
| TKNO | ALPHA TEKNOVA INC | $18,045,000 | +4.9% | 725,000 | 0.0% | 0.32% | +23.5% | |
| LFST | Sell | LIFESTANCE HEALTH GROUP INC | $17,725,000 | -49.4% | 1,222,408 | -2.8% | 0.31% | -40.3% |
| LVTX | LAVA THERAPEUTICS NV | $16,672,000 | -45.6% | 2,816,196 | 0.0% | 0.29% | -35.8% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $16,266,000 | -20.4% | 2,088,089 | 0.0% | 0.28% | -6.0% | |
| ZGNX | New | ZOGENIX INC | $15,409,000 | – | 1,014,414 | +100.0% | 0.27% | – |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $12,159,000 | -77.9% | 600,432 | -64.0% | 0.21% | -74.0% |
| PROF | PROFOUND MED CORP | $11,527,000 | -10.5% | 787,346 | 0.0% | 0.20% | +5.2% | |
| HOOK | Sell | HOOKIPA PHARMA INC | $10,863,000 | -36.1% | 1,844,305 | -0.6% | 0.19% | -25.0% |
| STXS | STEREOTAXIS INC | $9,983,000 | -44.2% | 1,855,504 | 0.0% | 0.17% | -34.3% | |
| CTSO | Sell | CYTOSORBENTS CORP | $8,481,000 | -13.9% | 1,044,434 | -19.9% | 0.15% | +1.4% |
| CABA | Sell | CABALETTA BIO INC | $8,468,000 | +41.4% | 696,377 | -0.0% | 0.15% | +66.3% |
| ITMR | Sell | ITAMAR MED LTDsponsored ads | $7,996,000 | -60.3% | 264,600 | -69.0% | 0.14% | -53.4% |
| AYLA | AYALA PHARMACEUTICALS INC | $7,573,000 | +11.3% | 667,816 | 0.0% | 0.13% | +30.7% | |
| BCEL | Sell | ATRECA INC | $7,289,000 | -65.2% | 1,170,006 | -52.4% | 0.13% | -59.0% |
| APRE | APREA THERAPEUTICS INC | $3,551,000 | +4.7% | 694,918 | 0.0% | 0.06% | +24.0% | |
| XERS | XERIS PHARMACEUTICALS INC | $3,329,000 | -39.8% | 1,358,825 | 0.0% | 0.06% | -29.3% | |
| YMTX | YUMANITY THERAPEUTICS INC | $614,000 | -11.4% | 59,487 | 0.0% | 0.01% | +10.0% | |
| TCDA | TRICIDA INC | $254,000 | +7.2% | 54,758 | 0.0% | 0.00% | 0.0% | |
| SYRS | SYROS PHARMACEUTICALS INC | $174,000 | -17.9% | 38,912 | 0.0% | 0.00% | 0.0% | |
| OVID | OVID THERAPEUTICS INC | $137,000 | -13.8% | 40,674 | 0.0% | 0.00% | 0.0% | |
| TLIS | Exit | TALIS BIOMEDICAL CORP | $0 | – | -363,849 | -100.0% | -0.06% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -237,360 | -100.0% | -0.08% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -394,355 | -100.0% | -0.09% | – |
| TMCI | Exit | TREACE MED CONCEPTS INC | $0 | – | -323,765 | -100.0% | -0.15% | – |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -240,933 | -100.0% | -0.21% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -843,578 | -100.0% | -0.27% | – |
| QSI | Exit | QUANTUM SI INC | $0 | – | -1,700,000 | -100.0% | -0.31% | – |
| PPD | Exit | PPD INC | $0 | – | -466,471 | -100.0% | -0.32% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -425,480 | -100.0% | -0.34% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -3,714,100 | -100.0% | -0.42% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -310,111 | -100.0% | -0.50% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -159,727 | -100.0% | -0.56% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -108,374 | -100.0% | -0.59% | – |
| SLQT | Exit | SELECTQUOTE INC | $0 | – | -2,411,957 | -100.0% | -0.69% | – |
| ZY | Exit | ZYMERGEN INC | $0 | – | -1,522,900 | -100.0% | -0.90% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -230,558 | -100.0% | -1.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.